本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cytek BioSciences

4.60
-0.0300-0.65%
盘后4.600.00000.00%16:10 EDT
成交量:55.25万
成交额:254.70万
市值:5.91亿
市盈率:-8.83
高:4.75
开:4.69
低:4.52
收:4.63
52周最高:6.18
52周最低:2.37
股本:1.29亿
流通股本:1.09亿
量比:0.55
换手率:0.51%
股息:- -
股息率:- -
每股收益(TTM):-0.5209
每股收益(LYR):-0.5209
净资产收益率:-18.05%
总资产收益率:-5.25%
市净率:1.73
市盈率(LYR):-8.83

数据加载中...

2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/19

重要事件披露

Form 8-K - Current report
2024/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/09

重要事件披露

Form 8-K - Current report
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities